Evan Y. Yu, MD, discusses the therapeutic options for metastatic castration-resistant prostate cancer (mCRPC) included in the National Comprehensive Cancer Network (NCCN) guidelines, such as ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment remaining a challenge despite decades of research. For years, the prostate-specific ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Chemo Pharma Laboratories Ltd., incorporated in the year 1942, is a Small Cap company (having a market cap of Rs 13.39 Crore) operating in Pharmaceuticals sector. Chemo Pharma Laboratories Ltd. key ...